Treatment de-escalation for HPV-driven oropharyngeal cancer: Where do we stand?

HPV-driven oropharyngeal cancers have significantly better survival rates than tobacco and alcohol induced head and neck cancers. As HPV-positive patients are younger, healthier and far more likely to survive their disease, long-term treatment side effects are becoming a major issue. This has led th...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirghani, Haitham, Blanchard, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862680/
https://www.ncbi.nlm.nih.gov/pubmed/29594236
http://dx.doi.org/10.1016/j.ctro.2017.10.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862680/
https://www.ncbi.nlm.nih.gov/pubmed/29594236
http://dx.doi.org/10.1016/j.ctro.2017.10.005

Ejemplares similares